GE HealthCare Technologies Inc.

GEHC · NASDAQ · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Donald Trump R · EXECUTIVE	net −$290K – $144K 19 disclosures · 8 bought / 11 sold · last Aug 26, 2026
Ro Khanna D · HOUSE · CA	−$156K – $348K −$151K – $365K today 36 filings · last Aug 3, 2026
Robert Bresnahan R · HOUSE · PA	−$13K – $29K −$16K – $25K today 3 filings · last May 15, 2025
Alan Armstrong R · SENATE · OK	$1K – $15K $1K – $15K today 1 filing · last Mar 27, 2026

Recent transactions

Trades from Feb 6, 2026 – Aug 26, 2026

Politician	Type	Filed after	Amount
Donald Trump R · EXECUTIVE	Sell	43 days Aug 26, 2026 → Oct 8, 2026	≥$15K
Donald Trump R · EXECUTIVE	Buy	52 days Aug 17, 2026 → Oct 8, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	57 days Jul 27, 2026 → Sep 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	60 days Jul 24, 2026 → Sep 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	64 days Jul 20, 2026 → Sep 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	67 days Jul 17, 2026 → Sep 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	67 days Jul 17, 2026 → Sep 22, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Buy	32 days Aug 3, 2026 → Sep 4, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	59 days Jun 24, 2026 → Aug 22, 2026	≥$15K
Donald Trump R · EXECUTIVE	Buy	60 days Jun 23, 2026 → Aug 22, 2026	≥$1K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

1,270

13F shares

397.4M

Total invested

$25.4B

Ownership

87.7%

New positions

141

Closed positions

181

Increased positions

542

Reduced positions

474

Put/Call ratio

0.55

Holder	Reported	Shares	Value	Δ Qtr
DODGE & COX	8/13/2026	37.9M	$2.4B	+20.93%
BLACKROCK, INC.	8/7/2026	37.5M	$2.4B	+4.12%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	29.7M	$1.9B	+2.98%
STATE STREET CORP	9/22/2026	20.9M	$1.3B	+1.57%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	20.3M	$1.3B	+5.69%
INVESCO LTD.	8/14/2026	18.3M	$1.2B	+91.28%
HARRIS ASSOCIATES L P	8/14/2026	15.3M	$981.3M	−1.70%
BARROW HANLEY MEWHINNEY & STRAUSS LLC	8/12/2026	13.5M	$861.3M	+13.22%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	12.9M	$820.8M	+3.81%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	8/14/2026	12.3M	$784.2M	+22.90%
JPMORGAN CHASE & CO	8/12/2026	10.3M	$671.9M	+15.22%
MORGAN STANLEY	8/13/2026	6.2M	$398.4M	−6.29%
NORGES BANK	8/12/2026	5.8M	$372.8M	—
DIMENSIONAL FUND ADVISORS LP	8/11/2026	5.4M	$345.8M	+0.04%
BOSTON PARTNERS	8/4/2026	5.2M	$329.8M	+1.09%
VAN ECK ASSOCIATES CORP	8/14/2026	4.5M	$286.9M	+4.11%
GOLDMAN SACHS GROUP INC	8/14/2026	4.4M	$284.6M	+36.14%
NORTHERN TRUST CORP	8/13/2026	3.9M	$252.1M	−2.80%
LSV ASSET MANAGEMENT	8/6/2026	3.5M	$222.9M	+91.77%
BANK OF AMERICA CORP /DE/	8/14/2026	3.2M	$208.0M	−21.37%
FMR LLC	8/13/2026	3.2M	$202.0M	+13.69%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.	8/14/2026	3.1M	$200.3M	—
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	8/14/2026	3.1M	$200.3M	−0.87%
TRIAN FUND MANAGEMENT, L.P.	8/12/2026	3.1M	$197.5M	+76194.36%
LEGAL & GENERAL GROUP PLC	8/14/2026	2.8M	$177.4M	−4.19%

Insider transactions

Insider	Type	Transacted	Price	Date
Grogan William K	A-AWARD	31.9K	$64.25	Sep 14
Grogan William K	A-AWARD	62.3K	—	Sep 14
Grogan William K	A-AWARD	12.8K	—	Sep 14
Grogan William K		0	—	Sep 14
Estrampes Catherine	F-INKIND	508	$70.56	Sep 3
Rackliffe Philip	F-INKIND	798	$70.56	Sep 3
Kass-Hout Taha	F-INKIND	1.5K	$70.56	Sep 3
Newcomb George A.	F-INKIND	112	$70.56	Sep 3
O'Neill Kevin Michael	F-INKIND	718	$70.56	Sep 3
Holton Adam Y	F-INKIND	673	$70.56	Sep 3

Analyst consensus

Buy19 analysts

Bearish · 0 · Hold · 8 · Bullish · 11

Earnings history

	EPS	Estimate
Q3 2024	$1.14	$1.05	Beat
Q4 2024	$1.45	$1.26	Beat
Q1 2025	$1.01	$0.91	Beat
Q2 2025	$1.06	$0.92	Beat
Q3 2025	$1.07	$1.05	Beat
Q4 2025	$1.44	$1.40	Beat
Q1 2026	$0.99	$1.04	Miss
Q2 2026	$1.13	$1.04	Beat

Peers

Company overview

IPO dateDec 15, 2022

CEOPeter J. Arduini

Employees54,000

SectorHealthcare

IndustryMedical - Devices

CountryUS

ExchangeNASDAQ Global Select

Websitewww.gehealthcare.com

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.